28 results on '"Herin, Fabrice"'
Search Results
2. Low performance of interferon gamma release assay Quantiferon-TB gold coupled or not with Pst1/3/lipoglycan humoral detection to predict Mycobacterium tuberculosis complex disease in a low-burden area
3. Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study
4. Blood pressure measurements after mRNA-SARS-CoV-2 tozinameran vaccination: a retrospective analysis in a university hospital in France
5. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics
6. Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal
7. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
8. Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
9. Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant
10. Impact de la prise en charge de la leucémie myéloïde chronique par les médicaments inhibiteurs des protéines kinases sur l’activité professionnelle
11. Pathologies en relation avec le travail (PRT) dans le secteur de l’administration publique : données du réseau national de vigilance et de prévention des pathologies professionnelles (RNV3P) 2001 à 2018
12. Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response
13. Impact of implementing of Custom Surgical Tray (CST) in ACLR procedure on Sustainable Development (SD)
14. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
15. Antibody titers and protection against a SARS-CoV-2 infection
16. Le fardeau de la pathologie mastocytaire : étude observationnelle, prospective
17. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration
18. Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration
19. One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection
20. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
21. Intérêt du dosage des chromuries parmi les salariés de l’aéronautique
22. Une initiative originale de prise en charge spécifique de l’épuisement des professionnels des secteurs santé et médicosociaux : le centre PEPS porté par le CHU de Toulouse
23. Les auteurs
24. Avant-propos
25. Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration.
26. Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection.
27. Strong Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody Response of Previously Infected Healthcare Workers Given 1 Dose of mRNA Vaccine.
28. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.